Genomic & Biopharma NewsPrince Harry, London School of Hygiene & Tropical Medicine organize roundtable to address needs of youth with HIV/AIDS
Global HIV leaders have committed to ensuring young people affected by HIV/AIDS play an integral part in shaping new research and policies to strengthen HIV prevention, testing and treatment in sub-Saharan Africa.
|News Medical Life Sciences, 2017-07-13 11:53:18|
TUM researchers decipher binding mechanism of antibody to environmental toxin
Summertime is barbecue time. However, when fat reacts with glowing coal, a substance chemists call benzopyrene is created. It is a widespread environmental toxin that can cause cancer in humans.
|News Medical Life Sciences, 2017-07-13 11:52:51|
Herpes virus in mountain gorillas has similarity to EBV found in humans
Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific Reports.
|News Medical Life Sciences, 2017-07-13 11:50:23|
In Texas, people with mental illness find work helping peers
Recovery coaches and peer mentors — known in Alcoholics Anonymous as “sponsors” — have for decades helped those addicted to alcohol or drugs.
|News Medical Life Sciences, 2017-07-13 11:33:47|
Tall and obese men at increased risk of aggressive prostate cancer, study finds
According to the team of researchers from the University of Oxford, height was not associated with the overall prostate cancer risk, but, with the addition of every 10 cm (3.9 inches) of height, the risk being diagnosed with aggressive prostate cancer and then death caused due to the disease increases by 21% and 17% respectively.
|News Medical Life Sciences, 2017-07-13 11:30:00|
NICE backs Humira, Enbrel and Stelara for plaque psoriasis in children
AbbVie’s Humira, Pfizer’s Enbrel, and Janssen’s Stelara are being recommended as options for treating plaque psoriasis in children and young people on the NHS.
|PharmaTimes, 2017-07-13 11:08:38|
Amgen’s Blincyto wins full US approval
Amgen’s Blincyto has been issued a full approval in the US as a treatment for adults and children with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL).
|PharmaTimes, 2017-07-13 11:06:01|
EU & UK pharma leaders write to Brexit negotiators
In an unprecedented move, eight leaders from associations representing the entire EU and UK pharmaceutical sector have written a joint letter to chief Brexit negotiators Michel Barnier and David Davis requesting that ongoing cooperation between the two territories for medicines be a negotiating priority.
|PharmaTimes, 2017-07-13 11:03:18|
EuroBiotech Report—Novartis CAR-T, Shire-Roche, Zealand IPO, Erytech alliance and Enterome-Nestlé joint venture
In this week's EuroBiotech Report, Novartis aces CAR-T panel, Shire hits Roche with injunction, Zealand files for IPO and more.
|Fierce Biotech, 2017-07-13 10:24:01|